CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,818,304 | +97.1% | 61,140 | +19.4% | 0.00% | – |
| Q2 2023 | $922,624 | +12.2% | 51,200 | 0.0% | 0.00% | – |
| Q1 2023 | $822,272 | -12.2% | 51,200 | 0.0% | 0.00% | – |
| Q4 2022 | $936,960 | -6.9% | 51,200 | 0.0% | 0.00% | – |
| Q3 2022 | $1,006,000 | +5.3% | 51,200 | 0.0% | 0.00% | – |
| Q2 2022 | $955,000 | +46.9% | 51,200 | +73.0% | 0.00% | – |
| Q1 2022 | $650,000 | -22.4% | 29,600 | +0.3% | 0.00% | – |
| Q4 2021 | $838,000 | +34.9% | 29,500 | 0.0% | 0.00% | – |
| Q3 2021 | $621,000 | +11.7% | 29,500 | 0.0% | 0.00% | – |
| Q2 2021 | $556,000 | +35.6% | 29,500 | +10.1% | 0.00% | – |
| Q1 2021 | $410,000 | +4.1% | 26,800 | -3.9% | 0.00% | – |
| Q4 2020 | $394,000 | -3.0% | 27,900 | +7.7% | 0.00% | – |
| Q3 2020 | $406,000 | -10.6% | 25,900 | 0.0% | 0.00% | – |
| Q2 2020 | $454,000 | +108.3% | 25,900 | +75.0% | 0.00% | – |
| Q1 2020 | $218,000 | -26.4% | 14,800 | +25.4% | 0.00% | – |
| Q4 2019 | $296,000 | +76.2% | 11,800 | +5.4% | 0.00% | – |
| Q3 2019 | $168,000 | -25.3% | 11,200 | +24.4% | 0.00% | – |
| Q2 2019 | $225,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |